Alternatives to ONWARD Medical

Developing soft, stretchable brain-computer interface platforms.

Developing ultra-high bandwidth brain-machine interfaces to connect humans and computers.

Advancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.

Developing wearable brain imaging systems using quantum sensing technology.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

Developing a cortical visual prosthesis to restore functional vision for the severely blind.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Biotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

Engineering scalable gene therapies for broader patient populations.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

AI-powered antibody discovery platform.

Developing ultrasound-mediated nonviral genetic medicines.

Pioneering vision restoration therapies for severe retinal degenerations.

Revolutionizing genomic analysis with innovative sequencing technology.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Developing advanced vision restoration technology through a retinal implant.

Developing lightweight bionic technology.

Developing a novel therapeutic approach for Alzheimer's disease.

Developing non-invasive ultrasound neuromodulation therapies for chronic immune-mediated diseases and inflammatory disorders.

Clinical-stage pharmaceutical company developing innovative oral therapies for diabetes and metabolic disorders.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Scalable, one-time curative in-vivo gene editing therapies.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.

Develops a brain-computer interface for treating epilepsy.

Elevating uterine health through innovative biomaterial therapies.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

Clinical-stage biotech company developing transformative cytokine therapies.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Optimizing the delivery and efficacy of cancer therapeutics through hyperthermic intravesical chemotherapy.

Advancing anti-PACAP therapies for the prevention of migraine and other headache disorders.

Developing disease-responsive advanced therapies through programmable gene control technology.

Developing breath-based diagnostics for lung diseases.

A clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.

Epitel develops AI-driven wireless brain health technologies for remote EEG monitoring, improving diagnosis and management of neurological conditions like epilepsy.

Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.

Develops advanced robotic exoskeletons to assist individuals with mobility impairments.

Firefly Neuroscience provides objective brain function assessments for mental illness using FDA-cleared Brain Network Analytics (BNA™) technology.

Develops and commercializes minimally invasive robotic platforms for the neuroscience field.

Biotechnology company developing new medicines for Parkinson's disease and other neurological disorders.

Pioneering intracoronary liquid biopsy to identify inflammatory drivers of cardiovascular disease.

OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.

Developing wearable robotics for neuromotor rehabilitation combined with AR/VR technologies.

Multisensory belt using touch stimuli to help people regain normal walking sensations.

Self-powered nanogenerator implanted to restore touch sensation by stimulating sensory nerves.

Continuous neurological monitoring wearable for hospitals, rehab, and home use.